Popular on TelAve
- Meredith Thomas Returns as Master of Ceremonies for International Women's Day Gala for 2025
- Spark Design Award Winners & New 2025 Call For Entry
- Post-Oscar Iftar Night Celebrates Academy Award-Winning Documentary No Other Land with a Packed House
- NaturismRE, ANF, and GNA Stand United for Naturist Rights in Australia – A Call for Global Support
- CitySwitch and OneVizion Partner to Significantly Reduce Accounting and Lease Administration Costs Annually with ASC 842-Compliant Leasing Solution
- Heartwarming News: UCLA & Lakers Honor Young Fan from New Mexico as "Laker For A Day"
- 3DCal.com Launches Revolutionary 3D Graphic Design System for Custom Motorcycle Decals
- AAGLA Signs With CredHub to Help Owners Comply with New Rent Reporting Requirements
- Rutgers University Student Wins "New Jersey's Top Student Entrepreneur" in EO's Global Student Entrepreneur Awards
- Jazz Legend Bob Holz Nomination-New Album Honoring Larry Coryell
Similar on TelAve
- Karen Mueller Leads the Charge in Infection Prevention as SterileCare Drives Meaningful Change in Catheter Care
- MANE DRINK to Launch Lion's Mane Mushroom Coffee in April — Pre-Orders Now Open for Nootropic Cold Brew
- Protecting Parental Rights: The Fight Against Coerced Mental Health Screening
- Restoration Dental Launches New Website to Enhance Patient Experience
- OneSolution Dental Implant Centers Announces All-on-X Digital Workflow Master Course in Palm Beach, FL
- Lineus Medical Completes $4.6 Million Series C Funding Round
- UN Report Exposes Psychiatric Abuses, Urges End to Forced Treatment Worldwide
- LifeVac, America's Leading Life Saving Device With Over 3000 Lives Saved, Featured on CNBC
- Longevity by Nature Partners with Leabon Group for Exclusive Telos95® Distribution in China
- Loong Wellness Now Offers ICBC-Covered RMT & Acupuncture in Vancouver
NeuraWorx Partners with Corundum Neuroscience to Initiate Clinical Feasibility Study, Develop Innovative Neurological Disease Treatment
TelAve News/10838813
EXCELSIOR, Minn. - TelAve -- NeuraWorx Medical Technologies, Inc., a neurotechnology therapeutics company, announced today a partnership with prominent neuroscience venture builder and fund, Corundum Neuroscience. As part of the collaboration, Corundum will provide resources, including the initial investment in a NeuraWorx seed funding round, aimed at advancing product development and initiating a clinical feasibility study to explore the efficacy and safety of its Cerebrovascular Pacing SystemTM novel technology.
"Corundum Neuroscience exists to solve significant brain health challenges by discovering, funding and supporting companies building breakthrough technologies in neuroscience," said Liron Nunez Weissman, CEO of Corundum Neuroscience. "We see a significant market opportunity for NeuraWorx's technology and believe in its potential to revolutionize the treatments of neurological diseases and improve human health and lifespan."
NeuraWorx is developing the Cerebrovascular Pacing System, a first-in-class wearable neurostimulator, which leverages established bioelectronic principles to enhance the brain's glymphatic and cerebrovascular systems, aiming to enhance waste clearance for improved brain health.
"Approaches that modulate the brain's environment are creating new opportunities for improved brain function and we believe that NeuraWorx has a unique solution that could unlock this potential," said Josh Schulman, PhD, chief scientist of Corundum Neuroscience. "We're thrilled to partner with them on this study that aims to explore how their stimulation can impact the brain in ways that could lead to new treatments for brain injuries and diseases, as well as potentially impacting neurodegeneration in a range of brain states."
More on TelAve News
As a long-term partner, Corundum Neuroscience will support NeuraWorx as it continues to develop the Cerebrovascular Pacing System by providing access to Corundum Neuroscience's advanced technological projects, scientific expertise and strategic funding.
The upcoming clinical study will be a crucial step in understanding the potential of NeuraWorx's Cerebrovascular Pacing product, paving the way for future advancements in the treatment of central nervous system (CNS) disorders. Both companies are committed to pushing the boundaries of neuroscience to deliver life-changing solutions to improve the lives of patients worldwide. NeuraWorx intends to pursue indications for traumatic brain injury (TBI), Alzheimer's dementia and other CNS disorders, while also developing preventive solutions tailored for military personnel, athletes and a variety of medical applications.
"We are excited to work with Corundum Neuroscience, whose expertise and resources in the neuroscience field will be instrumental in advancing our technology," said Dr. Kip Ludwig, co-founder of NeuraWorx, associate professor at the University of Wisconsin-Madison and co-director of the Wisconsin Institute for Translational Neuroengineering.
"This partnership aligns perfectly with our mission to alleviate suffering and enhance quality of life by developing groundbreaking treatments and preventive solutions for CNS disorders," added Chris Minar, CEO at NeuraWorx.
For more information about NeuraWorx Medical Technologies, Inc., and its innovative approach, visit www.neuraworx.com. To learn more about Corundum Neuroscience and its initiatives, visit www.cnsfund.com.
About NeuraWorx
NeuraWorx Medical Technologies, Inc., is developing a Cerebrovascular Pacing SystemTM, as a first-in-class bioelectronic solution for enhancing cerebral spinal fluid flow and blood flow in the brain. Its products are intended to be for both preventative and therapeutic use, for traumatic brain injury (TBI), Alzheimer's dementia, and other CNS diseases. NeuraWorx was founded in Minnesota, shortly after its science was developed at the University of Wisconsin and the Mayo Clinic. For company updates and information, follow NeuraWorx on LinkedIn or visit: https://www.neuraworx.com
More on TelAve News
About Corundum Neuroscience
Corundum Neuroscience is a venture builder and fund advancing transformative neuroscience solutions from lab-to-life. The Corundum Neuroscience team combines deep domain expertise with a track record of venture-building success to accelerate neuroscience solutions across the entire innovation lifecycle. Taking a long-term investment approach, Corundum Neuroscience helps researchers, entrepreneurs and startups develop life-changing solutions that target specific disease areas and outcomes to enhance people's health, longevity, and quality of life. Founded by former Joy Ventures executives, Corundum Neuroscience launched in September 2023 and is headquartered in Herzliya, Israel.
For company updates and information, follow Corundum Neuroscience on LinkedIn or visit https://cnsfund.com.
"Corundum Neuroscience exists to solve significant brain health challenges by discovering, funding and supporting companies building breakthrough technologies in neuroscience," said Liron Nunez Weissman, CEO of Corundum Neuroscience. "We see a significant market opportunity for NeuraWorx's technology and believe in its potential to revolutionize the treatments of neurological diseases and improve human health and lifespan."
NeuraWorx is developing the Cerebrovascular Pacing System, a first-in-class wearable neurostimulator, which leverages established bioelectronic principles to enhance the brain's glymphatic and cerebrovascular systems, aiming to enhance waste clearance for improved brain health.
"Approaches that modulate the brain's environment are creating new opportunities for improved brain function and we believe that NeuraWorx has a unique solution that could unlock this potential," said Josh Schulman, PhD, chief scientist of Corundum Neuroscience. "We're thrilled to partner with them on this study that aims to explore how their stimulation can impact the brain in ways that could lead to new treatments for brain injuries and diseases, as well as potentially impacting neurodegeneration in a range of brain states."
More on TelAve News
- Portland's Evolve & Unite Festival Brings a Transformational Experience to the Pacific Northwest
- School Launches 250 Students International Service Trips - Gives $1M to Global Education
- DivX Unveils Enhanced Guide on Converting MOV to MP4 for Effortless Video Conversion
- SourceCode Expands AI Factory Offerings with Atlas AI Ignite at GTC 2025
- Karen Mueller Leads the Charge in Infection Prevention as SterileCare Drives Meaningful Change in Catheter Care
As a long-term partner, Corundum Neuroscience will support NeuraWorx as it continues to develop the Cerebrovascular Pacing System by providing access to Corundum Neuroscience's advanced technological projects, scientific expertise and strategic funding.
The upcoming clinical study will be a crucial step in understanding the potential of NeuraWorx's Cerebrovascular Pacing product, paving the way for future advancements in the treatment of central nervous system (CNS) disorders. Both companies are committed to pushing the boundaries of neuroscience to deliver life-changing solutions to improve the lives of patients worldwide. NeuraWorx intends to pursue indications for traumatic brain injury (TBI), Alzheimer's dementia and other CNS disorders, while also developing preventive solutions tailored for military personnel, athletes and a variety of medical applications.
"We are excited to work with Corundum Neuroscience, whose expertise and resources in the neuroscience field will be instrumental in advancing our technology," said Dr. Kip Ludwig, co-founder of NeuraWorx, associate professor at the University of Wisconsin-Madison and co-director of the Wisconsin Institute for Translational Neuroengineering.
"This partnership aligns perfectly with our mission to alleviate suffering and enhance quality of life by developing groundbreaking treatments and preventive solutions for CNS disorders," added Chris Minar, CEO at NeuraWorx.
For more information about NeuraWorx Medical Technologies, Inc., and its innovative approach, visit www.neuraworx.com. To learn more about Corundum Neuroscience and its initiatives, visit www.cnsfund.com.
About NeuraWorx
NeuraWorx Medical Technologies, Inc., is developing a Cerebrovascular Pacing SystemTM, as a first-in-class bioelectronic solution for enhancing cerebral spinal fluid flow and blood flow in the brain. Its products are intended to be for both preventative and therapeutic use, for traumatic brain injury (TBI), Alzheimer's dementia, and other CNS diseases. NeuraWorx was founded in Minnesota, shortly after its science was developed at the University of Wisconsin and the Mayo Clinic. For company updates and information, follow NeuraWorx on LinkedIn or visit: https://www.neuraworx.com
More on TelAve News
- AI — Past, Present, and Future: Verb Presents Features Jay Preston
- New Free St. Patrick's Day Bingo Cards Announced – Print or Play Digitally!
- MANE DRINK to Launch Lion's Mane Mushroom Coffee in April — Pre-Orders Now Open for Nootropic Cold Brew
- Curated for You partners with Microsoft to unlock the future of AI-powered fashion discovery
- OpenSSL 3.1.2 Achieves FIPS 140-3 Validation
About Corundum Neuroscience
Corundum Neuroscience is a venture builder and fund advancing transformative neuroscience solutions from lab-to-life. The Corundum Neuroscience team combines deep domain expertise with a track record of venture-building success to accelerate neuroscience solutions across the entire innovation lifecycle. Taking a long-term investment approach, Corundum Neuroscience helps researchers, entrepreneurs and startups develop life-changing solutions that target specific disease areas and outcomes to enhance people's health, longevity, and quality of life. Founded by former Joy Ventures executives, Corundum Neuroscience launched in September 2023 and is headquartered in Herzliya, Israel.
For company updates and information, follow Corundum Neuroscience on LinkedIn or visit https://cnsfund.com.
Source: NeuraWorx Medical Technologies, Inc.
0 Comments
Latest on TelAve News
- The Heart of "Rooted In Rhythm": Bridging Gaps Through Music and Community
- 888BoatLaw.com Awards $1000 For FWC Pink Tag Bass Contest
- Dexter B. Jenkins: Championing Financial Literacy and Empowering Generational Wealth Through Faith-Based Guidance
- Best-Selling Author Maurice I. Crawford Unveils Explosive New Book
- Q4 2024 Industry Impact Report Highlights Shifts in Arizona Tech Employment Trends and Investments
- Webinar Announcement: AI Governance: Balancing Innovation and Responsibility
- Aterna AI Unveils AI Trading System with 67% Annual Returns for Career-Focused Professionals
- RoarFun attracts visitors with a motion flight simulator rental and virtual branding at the London Heathrow Aviation Carbon Sustainability conference
- 35th Annual Safe Sober T-Shirt Design Contest Winner Announced at Career Center High in Winston-Salem, North Carolina
- Expansive Estate in South Texas Seeks New Vision, 147 Acres Up for Grabs
- Events by Dubsdread Unveils the 2025 Orlando Wedding Pricing Guide
- Local Company Gets National Industry Recognition
- OneSolution Dental Implant Centers Announces All-on-X Digital Workflow Master Course in Palm Beach, FL
- Allen Field Co., Inc. Cuts Through the Hype: Real Packaging Solutions, No Buzzwords at Pack Expo Southeast 2025
- Digitek Solutions, an Alta Vista Company, Unveils Next-Generation Hosting Hardware at Arizona Data Center
- Himamauli Das Joins K2 Integrity as Senior Managing Director and Counsel
- Have a Special Japanese Honeymoon Experience in Nikko, Japan, With Photoshoot
- Tone Commander releases next-generation AS-SIP, APL-listed, and TSG-6 certified SIP phone with GigE, POE, and fiber SFP connectivity
- Andrew B. Louis is Working on His 14th Novel, Number 13 Will Be Out This Month
- Post-Oscar Iftar Night Celebrates Academy Award-Winning Documentary No Other Land with a Packed House